Latest Trials


EudraCT Number: 2016-001898-32 Sponsor Protocol Number: V87_30 Start Date:
Sponsor Name: Seqirus UK Limited
Full Title: A Phase 2, Randomized, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Several Doses of Antigen and MF59 Adjuvant Content in a Monovalent H5N1 Pandemic Influenza Vacc...
Medical condition: Prophylaxis for Influenza virus
Disease: Version SOC Term Classification Code Term Level
20.0 10021881 - Infections and infestations 10022000 Influenza PT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: EE (Ongoing) Outside EU/EEA
Trial results: (No results available)